Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shipman

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
The Journal of Biological Chemistry|January 21, 2011
Structural basis for selective small molecule kinase inhibition of activated c-MetKeith W Rickert, Sangita B Patel, Timothy J Allison, et al.
Nature Communications|February 6, 2021
Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activationChuan Hong, Noel J Byrne, Beata Zamlynny, et al.
Nature|April 6, 2017
Structural basis for selectivity and diversity in angiotensin II receptorsHaitao Zhang, Gye Won Han, Alexander Batyuk, et al.
Bioorganic & Medicinal Chemistry Letters|December 22, 2005
Potent 2-[(pyrimidin-4-yl)amine}-1,3-thiazole-5-carbonitrile-based inhibitors of VEGFR-2 (KDR) kinaseJohn T Sisko, Thomas J Tucker, Mark T Bilodeau, et al.
Journal of Medicinal Chemistry|November 30, 2004
Potent N-(1,3-thiazol-2-yl)pyridin-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for the hERG ion channelMark T Bilodeau, Adrienne E Balitza, Timothy J Koester, et al.
Journal of Biomolecular Screening|March 13, 2016
Integration of Affinity Selection-Mass Spectrometry and Functional Cell-Based Assays to Rapidly Triage Druggable Target Space within the NF-κB PathwayVictoria D Kutilek, Christine L Andrews, Matthew P Richards, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2017
Structural characterization of nonactive site, TrkA-selective kinase inhibitorsHua-Poo Su, Keith Rickert, Christine Burlein, et al.
Acta Crystallographica. Section D, Structural Biology|May 26, 2026
The evolving role of structural biology in pharma: integration of X-ray crystallography, cryo-electron microscopy and beyondJill E Chrencik, Hua Poo Su, Yacob Gomez Llorente, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
The Journal of Biological Chemistry|January 21, 2011
Structural basis for selective small molecule kinase inhibition of activated c-MetKeith W Rickert, Sangita B Patel, Timothy J Allison, et al.
Nature Communications|February 6, 2021
Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activationChuan Hong, Noel J Byrne, Beata Zamlynny, et al.
Nature|April 6, 2017
Structural basis for selectivity and diversity in angiotensin II receptorsHaitao Zhang, Gye Won Han, Alexander Batyuk, et al.
Bioorganic & Medicinal Chemistry Letters|December 22, 2005
Potent 2-[(pyrimidin-4-yl)amine}-1,3-thiazole-5-carbonitrile-based inhibitors of VEGFR-2 (KDR) kinaseJohn T Sisko, Thomas J Tucker, Mark T Bilodeau, et al.
Journal of Medicinal Chemistry|November 30, 2004
Potent N-(1,3-thiazol-2-yl)pyridin-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for the hERG ion channelMark T Bilodeau, Adrienne E Balitza, Timothy J Koester, et al.
Journal of Biomolecular Screening|March 13, 2016
Integration of Affinity Selection-Mass Spectrometry and Functional Cell-Based Assays to Rapidly Triage Druggable Target Space within the NF-κB PathwayVictoria D Kutilek, Christine L Andrews, Matthew P Richards, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2017
Structural characterization of nonactive site, TrkA-selective kinase inhibitorsHua-Poo Su, Keith Rickert, Christine Burlein, et al.
Acta Crystallographica. Section D, Structural Biology|May 26, 2026
The evolving role of structural biology in pharma: integration of X-ray crystallography, cryo-electron microscopy and beyondJill E Chrencik, Hua Poo Su, Yacob Gomez Llorente, et al.
Pageof 7